deltatrials
Completed PHASE3 NCT00007605

Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm

CSP #399 - The Effects of Antiarrhythmic Therapy in Maintaining Stability of Sinus Rhythm in Atrial Fibrillation

Sponsor: US Department of Veterans Affairs

Conditions Atrial Fibrillation Cerebrovascular Accident Death, Sudden
Interventions Amiodarone Sotalol
Updated 7 times since 2017 Last updated: Jun 13, 2011 Started: Apr 30, 1998 Primary completion: Oct 31, 2002 Completion: Dec 31, 2003

This PHASE3 trial investigates Atrial Fibrillation and Cerebrovascular Accident and is currently completed. US Department of Veterans Affairs leads this study, which shows 7 recorded versions since 1998 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Aug 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 2 earlier versions

  1. Jun 2018 — Aug 2018 [monthly]

    Completed PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Apr 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • US Department of Veterans Affairs
Data source: VA Office of Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States, Augusta, United States, Bay Pines, United States, Brockton, United States, Dallas, United States, Fargo, United States, Fresno, United States, Hines, United States, Iowa City, United States, Kansas City, United States and 18 more location s